Costs associated with tuberculosis diagnosis and treatment in Yemen for patients and public health services
AbstractThis study determined the costs associated with tuberculosis [TB] diagnosis and treatment for the public health services and patients in Sana'a, Yemen. Data were collected prospectively from 320 pulmonary and extrapulmonary TB patients [160 each] who were followed until completion of treatment. Direct medical and nonmedical costs and indirect costs were calculated. The proportionate cost to the patients for pulmonary TB and extrapulmonary TB was 76.1% and 89.4% respectively of the total for treatment. The mean cost to patients for pulmonary and extrapulmonary TB treatment was US$ 108.4 and US$ 328.0 respectively. The mean cost per patient to the health services for pulmonary and extrapulmonary TB treatment was US$ 34.0 and US$ 38.8 respectively. For pulmonary and extrapulmonary TB, drug treatment represented 59.3% and 77.9% respectively of the total cost to the health services. The greatest proportionate cost to patients for pulmonary TB treatment was time away from work [67.5% of the total cost], and for extrapulmonary TB was laboratory and X-ray costs [55.5%] followed by transportation [28.6%]
Othman, G.Q., lbrahim, M.I.M. & Raja'a, Y.A. (2012). Costs associated with tuberculosis diagnosis and treatment in Yemen for patients and public health services. EMHJ - Eastern Mediterranean Health Journal, 18 (4), 393-398, 2012 http://www.who.int/iris/handle/10665/118330
JournalEMHJ - Eastern Mediterranean Health Journal, 18 (4), 393-398, 2012
MetadataShow full item record
Showing items related by title and MeSH subject.
Using the Xpert MTB/RIF assay to detect pulmonary and extrapulmonary tuberculosis and rifampicin resistance in adults and children : expert group meeting report : 2013 World Health Organization (WHO/HTM/TB/2013.14, 2013)
Technique automatisée d’amplification de l’acide nucléique en temps réel pour la détection rapide et simultanée de la tuberculose et de la résistance à la rifampicine : système Xpert MTB/RIF : déclaration de principe Organisation mondiale de la Santé (WHO/HTM/TB/2011.4, 2011)